Dr. Laura Chico

Wedbush

Recent Articles

What Do Analysts Think About the Biopharma Set on Transforming Psychiatry 04/09/2026

Alto Neuroscience Inc. (ANRO:NYSE) is a clinical-stage biopharmaceutical company focused on transforming psychiatry through novel drug candidates.

Price Target on Psychiatric Drug Biotech Boosted 200% 10/27/2025

Alto Neuroscience Inc. (ANRO:NYSE) completed a US$50 million equity raise and announced plans to accelerate development of its recently acquired asset in treatment-resistant depression, noted a Wedbush report.